Nao Medical

Nao Medical's Bartow location in the Bronx, New York is a REMS-certified facility offering FDA-approved Spravato (esketamine) for eligible adults with treatment-resistant depression and for certain adults with major depressive disorder experiencing acute suicidal thoughts or actions. Esketamine works differently than traditional antidepressants, acting on glutamate rather than serotonin or norepinephrine.

Care includes a clinical evaluation, benefits verification, prior authorization support, monitored in-office dosing with a two-hour observation period, and transportation planning for treatment days. Each eligible patient is paired with a dedicated care manager.

The Bartow clinic gives Bronx patients a local Spravato access point for repeated monitored visits. Major insurance plans are accepted, including Medicaid, Medicare, and commercial coverage, with benefits verified before treatment begins.